Natural Antimicrobial Compounds in Veterinary Medicine: Focus on Companion Animals
Source abstract
Abstract
Companion animals, including dogs and cats, share close living environments with humans, making antimicrobial stewardship essential to prevent zoonotic transmission of resistant pathogens. The overuse and misuse of conventional antibiotics in veterinary medicine have accelerated the emergence of multidrug-resistant (MDR) microorganisms, prompting the need for alternative strategies. Natural compounds, such as antimicrobial peptides (AMPs), phytochemicals, chitosan-based polymers, and nutraceuticals, offer promising solutions due to their broad-spectrum activity, low resistance potential, and additional health-promoting properties. This review provides a comprehensive analysis of recent advances of the aforementioned compounds for companion animals, including their mechanisms of action, applications in feed and nutraceuticals, and therapeutic use in dermatological, gastrointestinal, and systemic infections. We discuss the current challenges related to bioavailability, safety, standardization, and regulatory frameworks, as well as future perspectives for integrating these agents into veterinary practice. Emphasis is placed on clinical evidence in dogs and cats, highlighting how natural antimicrobials can contribute to sustainable infection control and antimicrobial resistance mitigation under the One Health paradigm.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Antimicrobial Peptides and Activities · Dermatology and Skin Diseases · Veterinary Medicine and Surgery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Veterinary Sciences, University of Turin, 10095 Grugliasco, Italy
Department of Public Health and Pediatric Sciences, University of Turin, 10124 Turin, Italy
References (100+)
Show source-provided references
1. A History of Antimicrobial Drugs in Animals: Evolution and Revolution10.1111/jvp.12895 ↗
2. A Review on the Most Frequently Used Methods to Detect Antibiotic Residues in Bovine Raw Milk10.1016/j.idairyj.2023.105695 ↗
3. Implications of Veterinary Medicine in the Comprehension and Stewardship of Antimicrobial Resistance Phenomenon: From the Origin till Nowadays10.1016/j.vas.2022.100249 ↗
4. Cella, E., Giovanetti, M., Benedetti, F., Scarpa, F., Johnston, C., Borsetti, A., Ceccarelli, G., Azarian, T., Zella, D., and Ciccozzi, M. (2023). Joining Forces against Antibiotic Resistance: The One Health Solution. Pathogens, 12.10.3390/pathogens12091074 ↗
5. Pet Animals as Reservoirs of Antimicrobial-Resistant Bacteria10.1093/jac/dkh332 ↗
6. Patterns of Antimicrobial Agent Prescription in a Sentinel Population of Canine and Feline Veterinary Practices in the United Kingdom10.1016/j.tvjl.2017.03.010 ↗
7. A Randomised Controlled Trial to Reduce Highest Priority Critically Important Antimicrobial Prescription in Companion Animals10.1038/s41467-021-21864-3 ↗
8. Bandyopadhyay, S., and Samanta, I. (2020). Antimicrobial Resistance in Agri-Food Chain and Companion Animals as a Re-Emerging Menace in Post-COVID Epoch: Low- and Middle-Income Countries Perspective and Mitigation Strategies. Front. Vet. Sci., 7.10.3389/fvets.2020.00620 ↗
9. Gwenzi, W., Chaukura, N., Muisa-Zikali, N., Teta, C., Musvuugwa, T., Rzymski, P., and Abia, A.L.K. (2021). Insects, Rodents, and Pets as Reservoirs, Vectors, and Sentinels of Antimicrobial Resistance. Antibiotics, 10.10.3390/antibiotics10010068 ↗
10. Public Health Risk of Antimicrobial Resistance Transfer from Companion Animals
11. Aworh, M.K., Abiodun-Adewusi, O., Mba, N., Helwigh, B., and Hendriksen, R.S. (2021). Prevalence and Risk Factors for Faecal Carriage of Multidrug Resistant Escherichia coli among Slaughterhouse Workers. Sci. Rep., 11.10.1038/s41598-021-92819-3 ↗
12. Bacterial Zoonoses Transmitted by Household Pets: State-of-the-Art and Future Perspectives for Targeted Research and Policy Actions10.1016/j.jcpa.2015.03.004 ↗
13. Antimicrobial Resistance: A Global Multifaceted Phenomenon10.1179/2047773215Y.0000000030 ↗
14. Collignon, P.J., and McEwen, S.A. (2019). One Health—Its Importance in Helping to Better Control Antimicrobial Resistance. Trop. Med. Infect. Dis., 4.10.3390/tropicalmed4010022 ↗
15. Tompson, A.C., Mateus, A.L.P., Brodbelt, D.C., and Chandler, C.I.R. (2021). Understanding Antibiotic Use in Companion Animals: A Literature Review Identifying Avenues for Future Efforts. Front. Vet. Sci., 8.10.3389/fvets.2021.719547 ↗
16. Vercelli, C., Della Ricca, M., Re, M., Gambino, G., and Re, G. (2021). Antibiotic Stewardship for Canine and Feline Acute Urinary Tract Infection: An Observational Study in a Small Animal Hospital in Northwest Italy. Antibiotics, 10.10.3390/antibiotics10050562 ↗
17. Smith, R.P., May, H.E., AbuOun, M., Stubberfield, E., Gilson, D., Chau, K.K., Crook, D.W., Shaw, L.P., Read, D.S., and Stoesser, N. (2023). A Longitudinal Study Reveals Persistence of Antimicrobial Resistance on Livestock Farms Is Not Due to Antimicrobial Usage Alone. Front. Microbiol., 14.10.3389/fmicb.2023.1070340 ↗
18. Pharmacokinetics of Levofloxacin in Non-Lactating Goats and Evaluation of Drug Effects on Resistance in Coliform Rectal Flora10.1016/j.rvsc.2020.09.028 ↗
19. European Commission (2013). Commission Decision 2013/652/EU on the Monitoring and Reporting of Antimicrobial Resistance in Zoonotic and Commensal Bacteria. Off. J. Eur. Union, 303, 26–39. Available online: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32013D0652.
20. Driving Laboratory Standardization of Bacterial Culture and Antimicrobial Susceptibility Testing in Veterinary Clinical Microbiology in Europe and Beyond10.1128/JCM.02572-20 ↗
21. Antimicrobial Usage in Dogs and Cats in First Opinion Veterinary Practices in the UK10.1111/j.1748-5827.2011.01098.x ↗
22. Antimicrobial Agent Use in Small Animals: What Are the Prescribing Practices, Use of PK–PD Principles, and Extralabel Use in the United States?10.1111/jvp.12921 ↗
23. European Food Safety Authority (EFSA), and European Medicines Agency (EMEA) (2009). Joint Scientific Report on Meticillin Resistant Staphylococcus aureus (MRSA) in Livestock, Companion Animals and Foods. EFSA J., 7, 301r.10.2903/j.efsa.2009.301r ↗
24. European Union (2019). Regulation
25. (EU) 2019/6 of the European Parliament and of the Council on Veterinary Medicinal Products. Off. J. Eur. Union., 4, 1-25.
26. Encouraging Responsible Antibiotic Use by Pet Owners10.1136/vr.k1484 ↗
27. In vitro and In vivo Evaluation of a New Phytotherapic Blend to Treat Acute Externa Otitis in Dogs10.1111/jvp.13000 ↗
28. Canine Antimicrobial Peptides Are Effective against Resistant Bacteria and Yeasts10.1111/vde.12091 ↗
29. Antimicrobial Resistance and Current Alternatives in Veterinary Medicine
30. Antimicrobial peptides in domestic animals and their applications in veterinary medicine10.1016/j.peptides.2021.170576 ↗
31. Rossi, G., Pengo, G., Caldin, M., Palumbo Piccionello, A., Steiner, J.M., Cohen, N.D., Jergens, A.E., and Suchodolski, J.S. (2014). Comparison of Microbiological, Histological, and Immunomodulatory Parameters in Response to Treatment with Either Combination Antibiotics or Probiotics in Dogs with Inflammatory Bowel Disease. PLoS ONE, 9.10.1371/journal.pone.0094699 ↗
32. Antimicrobial Peptides: Agents of Border Protection for Companion Animals10.1111/j.1365-3164.2012.01037.x ↗
33. Stefanetti, V., Passamonti, F., and Rampacci, E. (2024). Antimicrobial Strategies Proposed for the Treatment of S. pseudintermedius and Other Dermato-Pathogenic Staphylococcus spp. in Companion Animals: A Narrative Review. Vet. Sci., 11.10.3390/vetsci11070311 ↗
34. Aporphinoid Alkaloids as Antimicrobial Agents against Yersinia enterocolitica10.1111/lam.13120 ↗
35. Effects of Isoquinoline Alkaloids from Macleaya cordata on Physiological, Immunological and Inflammatory Parameters in Healthy Beagles: Alkaloids in Dog Nutrition10.1111/jpn.13041 ↗
36. Cao, J., Chen, M., Xu, R., and Guo, M. (2022). Therapeutic Mechanisms of Berberine to Improve the Intestinal Barrier Function via Modulating Gut Microbiota, TLR4/NF-κB/MTORC Pathway and Autophagy in Cats. Front. Microbiol., 13.10.3389/fmicb.2022.961885 ↗
37. Mulukutla, A., Shreshtha, R., Deb, V., Chatterjee, P., Jain, U., and Chauhan, N. (2024). Recent Advances in Antimicrobial Peptide-Based Therapy. Bioorg. Chem., 145.10.1016/j.bioorg.2024.107151 ↗
38. Mechanism of the Binding, Insertion and Destabilization of Phospholipid Bilayer Membranes by Alpha-Helical Antimicrobial and Cell Non-Selective Membrane-Lytic Peptides10.1016/S0005-2736(99)00200-X ↗
39. Huan, Y., Kong, Q., Mou, H., and Yi, H. (2020). Antimicrobial Peptides: Classification, Design, Application and Research Progress in Multiple Fields. Front. Microbiol., 11.10.3389/fmicb.2020.582779 ↗
40. The Importance of Antimicrobial Peptides and Their Potential for Therapeutic Use in Ophthalmology10.1016/j.ijantimicag.2012.07.020 ↗
41. Effects of Rabbit Sacculus Rotundus Antimicrobial Peptides on the Intestinal Mucosal Immunity in Chickens10.3382/ps.2007-00353 ↗
42. Effects of Pig Antibacterial Peptides on Growth Performance and Intestine Mucosal Immunity of Broiler Chickens10.3382/ps.2008-00330 ↗
43. Antimicrobial Peptides: Promising Alternatives in the Post-Feeding Antibiotic Era10.1002/med.21542 ↗
44. Combinations of Early Generation Antibiotics and Antimicrobial Peptides Are Effective against a Broad Spectrum of Bacterial Biothreat Agents10.1016/j.micpath.2020.104050 ↗
45. A Review of Antimicrobial Peptides: Its Function, Mode of Action and Therapeutic Potential10.1007/s10989-021-10325-6 ↗
46. Evaluation of Canine Antimicrobial Peptides in Infected and Noninfected Chronic Atopic Skin10.1111/j.1365-3164.2012.01091.x ↗
47. Activity, Expression and Genetic Variation of Canine β-Defensin 103: A Multifunctional Antimicrobial Peptide in the Skin of Domestic Dogs10.1159/000334566 ↗
48. Hyun, J.E., and Hwang, C.Y. (2024). Antimicrobial Peptide Reduces Cytotoxicity and Inflammation in Canine Epidermal Keratinocyte Progenitor Cells Induced by Pseudomonas aeruginosa Infection. Vet. Sci., 11.10.3390/vetsci11060235 ↗
49. Jarosiewicz, M., Garbacz, K., Neubauer, D., and Kamysz, W. (2020). In vitro Efficiency of Antimicrobial Peptides against Staphylococcal Pathogens Associated with Canine Pyoderma. Animals, 10.10.3390/ani10030470 ↗
50. Taheri-Araghi, S. (2024). Synergistic action of antimicrobial peptides and antibiotics: Current understanding and future directions. Front. Microbiol., 15.10.3389/fmicb.2024.1390765 ↗
51. Evaluating the Safety and Functionality of a Novel Compound Containing Prebiotics, Probiotics, and Postbiotics in Healthy Cats and Dogs10.5455/OVJ.2025.v15.i5.11 ↗
52. Evidence-Based Use of Biotics in the Management of Gastrointestinal Disorders in Dogs and Cats10.1002/vetr.4916 ↗
53. Value of Probiotics in Canine and Feline Gastroenterology10.1016/j.cvsm.2020.09.011 ↗
54. Yang, Q., and Wu, Z. (2023). Gut probiotics and health of dogs and cats: Benefits, applications, and underlying mechanisms. Microorganisms, 11.10.3390/microorganisms11102452 ↗
55. The influence of ‘biotics’ on the gut microbiome of dogs and cats10.1002/vetr.4914 ↗
56. Randomized, controlled, crossover trial of prevention of antibiotic-induced gastrointestinal signs using a synbiotic mixture in healthy research dogs10.1111/jvim.15553 ↗
57. Antimicrobial Activity of Tea Catechin against Canine Oral Bacteria and the Functional Mechanisms10.1292/jvms.16-0198 ↗
58. The effect of cranberry (Vaccinium macrocarpon) consumption on Escherichia coli adherence to feline uroepithelial cells in a blind randomised cross-over trial in cats10.2478/jvetres-2024-0055 ↗
59. Dog food production using curcumin as antioxidant: Effects of intake on animal growth, health and feed conservation10.1080/1745039X.2020.1769442 ↗
60. Suemanotham, N., Photcharatinnakorn, P., Chantong, B., Buranasinsup, S., Phochantachinda, S., Sakcamduang, W., Reamtong, O., and Thiangtrongjit, T. (2022). Curcuminoid supplementation in canine diabetes mellitus and its complications using proteomic analysis. Front. Vet. Sci., 9.10.3389/fvets.2022.1057972 ↗
61. Della Rocca, G., Schievano, C., Di Salvo, A., Conti, M.B., and Della Valle, M.F. (2023). Palmitoyl-glucosamine co-micronized with curcumin for maintenance of meloxicam-induced pain relief in dogs with osteoarthritis pain. BMC Vet. Res., 19.10.1186/s12917-023-03594-4 ↗
62. Nakamura, T., Kitana, J., Fujiki, J., Takase, M., Iyori, K., Simoike, K., and Iwano, H. (2020). Lytic Activity of Polyvalent Staphylococcal Bacteriophage PhiSA012 and Its Endolysin Lys-PhiSA012 against Antibiotic-Resistant Staphylococcal Clinical Isolates from Canine Skin Infection Sites. Front. Med., 7.10.3389/fmed.2020.00234 ↗
63. Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies10.1128/CMR.00071-17 ↗
64. López, V., Pavela, R., Gómez-Rincón, C., Les, F., Bartolucci, F., Galiffa, V., Petrelli, R., Cappellacci, L., Maggi, F., and Canale, A. (2019). Efficacy of Origanum syriacum Essential Oil against the Mosquito Vector Culex quinquefasciatus and the Gastrointestinal Parasite Anisakis simplex, with Insights on Acetylcholinesterase Inhibition. Molecules, 24.10.3390/molecules24142563 ↗
65. Antimicrobial Activity of Thyme Oil, Oregano Oil, Thymol and Carvacrol against Sensitive and Resistant Microbial Isolates from Dogs with Otitis Externa10.1111/vde.12794 ↗
66. Antimicrobial Activity of Two Essential Oils
67. Melaleuca alternifolia (Tea Tree) Oil: A Review of Antimicrobial and Other Medicinal Properties10.1128/CMR.19.1.50-62.2006 ↗
68. Tea Tree Oil: Contact Allergy and Chemical Composition10.1111/cod.12591 ↗
69. Oliva, A., Costantini, S., De Angelis, M., Garzoli, S., Božović, M., Mascellino, M., Vullo, V., and Ragno, R. (2018). High Potency of Melaleuca alternifolia Essential Oil against Multi-Drug Resistant Gram-Negative Bacteria and Methicillin-Resistant Staphylococcus aureus. Molecules, 23.10.3390/molecules23102584 ↗
70. Oliveira, J.R., Camargo, S., and Oliveira, L. (2019). Rosmarinus officinalis L. (Rosemary) as Therapeutic and Prophylactic Agent. J. Biomed. Sci., 26.10.1186/s12929-019-0499-8 ↗
71. Biological Activities of Lavender Essential Oil10.1002/ptr.1103 ↗
72. Inhibition of Cytokine Production and Arachidonic Acid Metabolism by Eucalyptol (1,8-Cineole) in Human Blood Monocytes in vitro
73. Ebani, V.V., Nardoni, S., Bertelloni, F., Najar, B., Pistelli, L., and Mancianti, F. (2017). Antibacterial and Antifungal Activity of Essential Oils against Pathogens Responsible for Otitis Externa in Dogs and Cats. Medicines, 4.10.3390/medicines4020021 ↗
74. In vitro Activity of Essential Oils against Microbial Isolates from Otitis Externa Cases in Dogs
75. Essential Oil Pharmaceuticals for Killing Ectoparasites on Dogs10.4142/jvs.23189 ↗
76. Open-Field Study Comparing an Essential Oil-Based Shampoo with Miconazole/Chlorhexidine for Haircoat Disinfection in Cats with Spontaneous Microsporiasis10.1177/1098612X15625709 ↗
77. Toxicity of Melaleuca Oil and Related Essential Oils Applied Topically on Dogs and Cats
78. Addition of a Blend of Essential Oils (Clove, Rosemary and Oregano) and Vitamin E to Replace Conventional Chemical Antioxidants in Dog Feed: Effects on Food Quality and Health of Beagles10.1080/1745039X.2021.1960091 ↗
79. Adverse Reactions from Essential Oil-Containing Natural Flea Products Exempted from Environmental Protection Agency Regulations in Dogs and Cats10.1111/j.1476-4431.2012.00780.x ↗
80. Mráz, P., Kopecký, M., Hasoňová, L., Hoštičková, I., Vaníčková, A., Perná, K., Žabka, M., and Hýbl, M. (2025). Antibacterial activity and chemical composition of popular plant essential oils and their positive interactions in combination. Molecules, 30.10.3390/molecules30091864 ↗
81. Topical tea tree oil effective in canine localised pruritic dermatitis: A multi-centre randomised double-blind controlled clinical trial in veterinary practice
82. Móritz, A.V., Kovács, H., Jerzsele, Á., Psáder, R., and Farkas, O. (2024). Flavonoids in Mitigating the Adverse Effects of Canine Endotoxemia. Front. Vet. Sci., 11.10.3389/fvets.2024.1396870 ↗
83. Antimicrobial Activity of Flavonoids10.1016/j.ijantimicag.2005.09.002 ↗
84. do Nascimento, J.B., and da Costa, J.G.M. (2025). Flavonoids: A Review of Antibacterial Activity against Gram-Negative Bacteria. Int. J. Microbiol., 2025.10.1155/ijm/9961121 ↗
85. In vitro Antimicrobial Activity of the Leaf Extract of Harungana madagascariensis Lam. Ex Poir. (Hypericaceae) against Strains Causing Otitis Externa in Dogs and Cats10.1556/avet.55.2007.1.10 ↗
86. Bruni, N., Capucchio, M.T., Biasibetti, E., Pessione, E., Cirrincione, S., Giraudo, L., Corona, A., and Dosio, F. (2016). Antimicrobial Activity of Lactoferrin-Related Peptides and Applications in Human and Veterinary Medicine. Molecules, 21.10.3390/molecules21060752 ↗
87. In vitro Activity of Lactoferricin Solution against Malassezia pachydermatis from Otitis Externa in Dogs and Cats10.1111/vde.12973 ↗
88. Lactoferrin from Canine Neutrophils: Isolation and Physicochemical and Antimicrobial Properties
89. Non-Immunoglobulin Defense Factors in Canine Saliva and Effects of a Tooth Gel Containing Antibacterial Enzymes10.1177/089875640001700303 ↗
90. Iacopetti, I., Perazzi, A., Badon, T., Bedin, S., Contiero, B., and Ricci, R. (2017). Salivary pH, Calcium, Phosphorus and Selected Enzymes in Healthy Dogs: A Pilot Study. BMC Vet. Res., 13.10.1186/s12917-017-1256-4 ↗
91. Özhan, H.K., Duman, H., Bechelany, M., and Karav, S. (2025). Lactoperoxidase: Properties, Functions, and Potential Applications. Int. J. Mol. Sci., 26.10.20944/preprints202505.0314.v1 ↗
92. Lactoferrin: A Multiple Bioactive Protein—An Overview10.1016/j.bbagen.2011.06.018 ↗
93. Giansanti, F., Panella, G., Leboffe, L., and Antonini, G. (2016). Lactoferrin from Milk: Nutraceutical and Pharmacological Properties. Pharmaceuticals, 9.10.3390/ph9040061 ↗
94. Gruden, Š., and Poklar Ulrih, N. (2021). Diverse Mechanisms of Antimicrobial Activities of Lactoferrins, Lactoferricins, and Other Lactoferrin-Derived Peptides. Int. J. Mol. Sci., 22.10.3390/ijms222011264 ↗
95. Nawaz, N., Wen, S., Wang, F., Nawaz, S., Raza, J., Iftikhar, M., and Usman, M. (2022). Lysozyme and Its Application as Antibacterial Agent in Food Industry. Molecules, 27.10.3390/molecules27196305 ↗
96. Bolesławska, I., Bolesławska-Król, N., Jakubowski, K., Przysławski, J., and Drzymała-Czyż, S. (2025). Lactoferrin—A Regulator of Iron Homeostasis and Its Implications in Cancer. Molecules, 30.10.3390/molecules30071507 ↗
97. Characterization of Cytoplasmic Lysozyme Immunoreactivity as a Histiocytic Marker in Normal Canine Tissues10.1177/030098588602300616 ↗
98. Perazzi, A., Ricci, R., Contiero, B., and Iacopetti, I. (2022). Evaluation of Salivary Biochemistry in Dogs with and without Plaque, Calculus, and Gingivitis: Preliminary Results. Animals, 12.10.3390/ani12091091 ↗
99. Use of antimicrobial photodynamic therapy in the treatment of otitis caused by Malassezia spp. in domestic dogs10.21708/avb.2023.17.4.11844 ↗
100. In vitro antimicrobial photodynamic therapy using tetra-cationic porphyrins against multidrug-resistant bacteria isolated from canine otitis10.1016/j.pdpdt.2020.101982 ↗